Abbott’s Gallant ICD and CRT-D Device Receives CE Mark in the EU

 Abbott’s Gallant ICD and CRT-D Device Receives CE Mark in the EU

Abbott’s Gallant ICD and CRT-D Device Receives CE Mark in the EU

Shots:

  • Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices offer patients engagement and remote monitoring via smartphone to patients with abnormal heart rhythms & HF
  • The Gallant system pairs with Abbott’s secure myMerlinPulse mobile app to improve the connectivity b/w the doctors & patients. The app allows the physician to monitor patients remotely, identification of asymptomatic episodes as well as patient-triggered transmissions, leading to earlier intervention and reduction in clinical burden
  • The Gallant CRT-D system includes Abbott’s MultiPoint Pacing and SyncAV features to aid patients to respond to CRT therapy while the ICD device includes Abbott’s TailoredTherapy suite to help physicians more instinctively program their patient’s devices

Click here ­to­ read full press release/ article | Ref: Abbott | Image: Livemint

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post